Fungal dysbiosis in mucosa-associated microbiota of Crohn's disease patients

Journal of Crohn's and Colitis

Volumn 10, Issue 3, 2016, Pages 296-305

  Liguori, Giuseppina ^a   Lamas, Bruno ^b,c   Richard, Mathias L ^c,d   Brandi, Giovanni ^a   da Costa, Gregory ^c,d   Hoffmann, Thomas W ^c,d   Di Simone, Massimo Pierluigi ^a   Calabrese, Carlo ^a   Poggioli, Gilberto ^a   Langella, Philippe ^c,d   Campieri, Massimo ^a   Sokol, Harry ^b,c,d,e  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Centre National de la Recherche Scientifique   (France)

^c Service Hospitalo Universitaire   (France)

^d UMR1319 MICALIS   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Fungal microbiota; Inflammatory bowel disease; Mucosa associated microbiota

Indexed keywords

ADULT; ARTICLE; ASCOMYCETES; BASIDIOMYCETES; CANDIDA GLABRATA; CLINICAL ARTICLE; CROHN DISEASE; DYSBIOSIS; FEMALE; FILOBASIDIUM; FUNGAL DYSBIOSIS; FUSOBACTERIA; HUMAN; INTESTINE FLORA; MALE; MUCOSA; NONHUMAN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEOBACTERIA; REAL TIME POLYMERASE CHAIN REACTION; SACCHAROMYCES CEREVISIAE; SEQUENCE ANALYSIS; BIODIVERSITY; CASE CONTROL STUDY; COLON; DISEASE COURSE; FUNGUS; GENETICS; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED;

FUNGAL DNA;

ADULT; BIODIVERSITY; CASE-CONTROL STUDIES; COLON; CROHN DISEASE; DISEASE PROGRESSION; DNA, FUNGAL; DYSBIOSIS; FEMALE; FUNGI; GASTROINTESTINAL MICROBIOME; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84963791962     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1093/ecco-jcc/jjv209     Document Type: Article

References (72)

1. Savage DC. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 1977;31:107-33.
2. Reiners JJ, Clift R, Mathieu P. Suppression of cell cycle progression by flavonoids: dependence on the aryl hydrocarbon receptor. Carcinogenesis 1999;20:1561-6.
3. Bernet MF, Brassart D, Neeser JR, Servin AL. Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 1994;35:483-9.
4. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007;448:427-34.
5. Frank DN, Amand ALS, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 2007;104:13780-5.
6. Baumgart M, Dogan B, Rishniw M, et al. Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum. ISME J 2007;1:403-18.
7. Sokol H, Seksik P. The intestinal microbiota in inflammatory bowel diseases: time to connect with the host. Curr Opin Gastroenterol 2010;26:327-31.
8. Manichanh C, Borruel N, Casellas F, Guarner F. The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 2012; 9:599-608.
9. Zoetendal EG, Von Wright A, Vilpponen-Salmela T, Ben-Amor K, Akker-mans AD, de Vos WM. Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol 2002;68:3401-7.
10. Lepage P, Seksik P, Sutren M, et al. Biodiversity of the mucosa-associated microbiota is stable along the distal digestive tract in healthy individuals and patients with IBD. Inflamm Bowel Dis 2005;11:473-80.
11. Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science 2005;308:1635-8.
12. Richard ML, Lamas B, Liguori G, Hoffmann TW, Sokol H. Gut Fungal Microbiota: The Yin and Yang of Inflammatory Bowel Disease. Inflamm Bowel Dis 2015;21:65665.
13. Chehoud C, Albenberg LG, Judge C, et al. Fungal Signature in the Gut Microbiota of Pediatric Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis 2015;21:1948-56.
14. Mukhopadhya I, Hansen R, Meharg C, et al. The fungal microbiota of de-novo paediatric inflammatory bowel disease. Microbes Infect 2015;17:304-10.
15. McKenzie H, Main J, Pennington C, Parratt D. Antibody to selected strains of Saccharomyces cerevisiae [baker's and brewer's yeast] and Candida albicans in Crohn's disease. Gut 1990;31:536-8.
16. Vermeire S, Peeters M, Vlietinck R, et al. Anti-saccharomyces cerevisiae antibodies [ASCA], phenotypes of IBD, and intestinal permeability: a study in IBD families. Inflamm Bowel Dis 2001;7:8-15.
17. Quinton JF, Sendid B, Reumaux D, et al. Anti-saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoanti-bodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1998;42:788-91.
18. Standaert-Vitse A, Sendid B, Joossens M, et al. Candida albicans colonization and ASCA in familial Crohn's disease. Am J Gastroenterol 2009;104:1745-53.
19. Jawhara S, Thuru X, Standaert-Vitse A, et al. Colonization of mice by Candida albicans is promoted by chemically induced colitis and augments inflammatory responses through galectin-3. J Infect Dis 2008;197:972-80.
20. Zwolinska-Wcislo M, Brzozowski T, Budak A, et al. Effect of Candida colonization on human ulcerative colitis and the healing of inflammatory changes of the colon in the experimental model of colitis ulcerosa. J Physiol Pharmacol 2009;60:107-18.
21. Jawhara S, Poulain D. Decreases inflammation and intestinal colonization by Candida albicans in a mouse model of chemically-induced colitis. Med Mycol 2007;45:691-700.
22. Iliev ID, Funari VA, Taylor KD, et al. Interaction between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science 2012; 336:1314-17.
23. Sokol H, Conway KL, Zhang M, et al. Card9 mediates intestinal epithelial cell restitution, T-helper 17 responses, and control of bacterial infection in mice. Gastroenterology 2013;145:591-601.
24. Franke A, Balschun T, Sina C, et al. Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 [IL17REL]. Nat Genet 2010;42:292-4.
25. McGovern DP, Gardet A, Törkvist L, et al. Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet 2010;42:332-7.
26. Viaud S, Saccheri F, Mignot G, et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 2013;22:971-6.
27. Schmieder R, Edwards R. Quality control and preprocessing of metagenomic datasets. Bioinformatics 2011;27:863-4.
28. Magoč T, Salzberg SL. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics 2011;27:2957-63.
29. Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 2010;7:335-6.
30. Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 2010;26:2460-1.
31. McDonald D, Price MN, Goodrich J, et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J 2012;6:610-8.
32. Ihrmark K, Bödeker IT, Cruz-Martinez K, et al. New primers to amplify the fungal ITS2 region-evaluation by 454-sequencing of artificial and natural communities. FEMS Microbiol Ecol 2012;82:666-77.
33. Op De Beeck M, Lievens B, Busschaert P, Declerck S, Vangronsveld J, Colpaert JV. Comparison and validation of some ITS primer pairs useful for fungal metabarcoding studies. PLoS One 2014;16:e97629.
34. Lohtander K, Myllys L, Sundin R, Källersjö M, Tehler A. The species pair concept in the lichen Dendrographa leucophaea [Arthoniales]: Analyses based on ITS sequences. Bryologist 1998;101:404-11.
35. Reinhard A, Bressenot A, Dassonneville R, et al. Photodynamic therapy relieves colitis and prevents colitis-associated carcinogenesis in mice. Inflamm Bowel Dis 2015;21:985-95.
36. Kõljalg U, Nilsson RH, Abarenkov K, et al. Towards a unified paradigm for sequence-based identification of fungi. Mol Ecol 2013;22:5271-7.
37. Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol 2011;12:R60.
38. Bibiloni R, Mangold M, Madsen KL, Fedorak RN, Tannock GW. The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients. J Med Microbiol 2006;55:1141-9.
39. Walker AW, Sanderson JD, Churcher C, et al. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol 2011;11:7.
40. Morgan XC, Huttenhower C. Meta'omic analytic techniques for studying the intestinal microbiome. Gastroenterology 2014;146:1437-48.
41. Munro J, Mayberry JF, Matthews N, Rhodes J. Chlamydia and Crohn's disease. Lancet 1979;2:45-6.
42. Liu Y, Van Kruiningen HJ, West AB, Cartun RW, Cortot A, Colombel JF. Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease. Gastroenterology 1995;108:1396-404.
43. Martin HM, Campbell BJ, Hart CA, et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 2004;127:80-93.
44. Subramanian S, Rhodes JM, Hart CA, et al. Characterization of epithelial IL-8 response to inflammatory bowel disease mucosal E. coli and its inhibition by mesalamine. Inflamm Bowel Dis 2008;14:162-75.
45. Maynard CL, Elson CO, Hatton RD, Weaver CT. Reciprocal interactions of the intestinal microbiota and immune system. Nature 2012;489:231-41.
46. Mukhopadhya I, Hansen R, El-Omar EM, Hold GL. IBD-what role do Proteobacteria play? Nat Rev Gastroenterol Hepatol 2012;9:219-30.
47. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009;9:313-23.
48. Korzenik JR. Is Crohn's disease due to defective immunity? Gut 2007;56:2-5.
49. Nuding S, Fellermann K, Wehkamp J, Stange EF. Reduced mucosal antimicrobial activity in Crohn's disease of the colon. Gut 2007;56:1240-7.
50. Wehkamp J, Harder J, Weichenthal M, et al. NOD2 [CARD15] mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut 2004;53:1658-64.
51. Dharmani P, Strauss J, Ambrose C, Allen-Vercoe E, Chadee K. Fusobacterium nucleatum infection of colonic cells stimulates MUC2 mucin and tumor necrosis factor alpha. Infect Immun 2011;79:2597-607.
52. Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut micro-biota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 2008;105:16731-6.
53. Qiu X, Zhang M, Yang X, Hong N, Yu C. Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis. J Crohns Colitis 2013;7:558-68.
54. Carlsson AH, Yakymenko O, Olivier I, et al. Faecalibacterium prausnitzii supernatant improves intestinal barrier function in mice DSS colitis. Scand J Gastroenterol 2013;48:1136-44.
55. Sokol H, Seksik P, Furet JP, et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 2009;15:1183-9.
56. Rajca S, Grondin V, Louis E, et al. Alterations in the intestinal microbiome [dysbiosis] as a predictor of relapse after infliximab withdrawal in Crohn's disease. Inflamm Bowel Dis 2014;20:978-86.
57. Hoffmann C, Dollive S, Grunberg S, et al. Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents. PLoS One 2013;8:e66019.
58. Li Q, Wang C, Tang C, He Q, Li N, Li J. Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn's disease. J Clin Gastroenterol 2014;48:513-23.
59. Ott SJ, Kuhbacher T, Musfeldt M, et al. Fungi and inflammatory bowel diseases: Alterations of composition and diversity. Scand J Gastroenterol 2008;43:831-41.
60. Seider K, Brunke S, Schild L, et al. The facultative intracellular pathogen Candida glabrata subverts macrophage cytokine production and phagolysosome maturation. J Immunol 2011;187:3072-86.
61. Seider K, Gerwien F, Kasper L, et al. Immune evasion, stress resistance, and efficient nutrient acquisition are crucial for intracellular survival of Candida glabrata within macrophages. Eukaryot Cell 2014;13:170-83.
62. Shen XY, Cheng YL, Cai CJ, Fan L, Gao J, Hou CL. Diversity and antimicrobial activity of culturable endophytic fungi isolated from moso bamboo seeds. PLoS One 2014;9:e95838.
63. Morales H, Marín S, Rovira A, Ramos AJ, Sanchis V. Patulin accumulation in apples by Penicillium expansum during postharvest stages. Lett Appl Microbiol 2007;44: 30-5.
64. Liu J, Wisniewski M, Droby S, Vero S, Tian S, Hershkovitz V. Glycine betaine improves oxidative stress tolerance and biocontrol efficacy of the antagonistic yeast Cystofilobasidium infirmominiatum. Int J Food Micro-biol 2011;146:76-83.
65. Vadkertiová R, Sláviková E. Killer activity of yeasts isolated from natural environments against some medically important Candida species. Pol J Microbiol 2007;56:39-43.
66. Mitchell AM, Strobel GA, Moore E, Robison R, Sears J. Volatile antimicrobials from Muscodor crispans, a novel endophytic fungus. Microbiology 2010;156[Pt 1]:270-7.
67. Chang CW, Chang HS, Cheng MJ, et al. Inhibitory effects of constituents of an endophytic fungus Hypoxylon investiens on nitric oxide and interleukin-6 production in RAW264.7 macrophages. Chem Biodivers 2014;11:949-61.
68. Chen C, Hu SY, Luo DQ, Zhu SY, Zhou CQ. Potential antitumor agent from the endophytic fungus Pestalotiopsis photiniae induces apoptosis via the mitochondrial pathway in HeLa cells. Oncol Rep 2013;30:1773-81.
69. Canonici A, Pellegrino E, Siret C, et al. Saccharomyces boulardii improves intestinal epithelial cell restitution by inhibiting αvβ5 integrin activation state. PLoS One 2012;7:e45047.
70. Canonici A, Siret C, Pellegrino E, et al. Saccharomyces boulardii improves intestinal cell restitution through activation of the α2β1 integrin collagen receptor. PLoS One 2011;6:e18427.
71. Wu X, Vallance BA, Boyer L, et al. Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors. Am J Physiol Gastrointest Liver Physiol 2008;294:G295-G306.
72. Pan W, Liao W, Hagen F, et al. Meningitis caused by Filobasidium uniguttulatum: case report and overview of the literature. Mycoses 2012;55:105-9.